5-HT3 antagonist for cognition improvement in schizophrenia: a double blind, placebo-controlled trial
Introduction: Patients with schizophrenia characteristically exhibit cognitive deficits. The level of cognitive impairment is found to predict the functional outcome of the illness more strongly than the severity of positive or negative symptoms. The purpose of this study was to assess the...
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artikel |
| Taal: | English |
| Gepubliceerd in: |
Iran University of Medical Sciences
2010-01-01
|
| Reeks: | Basic and Clinical Neuroscience |
| Onderwerpen: | |
| Online toegang: | http://bcn.iums.ac.ir/browse.php?a_code=A-10-1-19&slc_lang=en&sid=1 |